Market defining Pharma Expo, PharmaLytica returns with over 300 Brands
Mumbai, 28 May 2022: Informa Markets in India, the leading B2B exhibitions organiser, is back with the 8th edition of the PharmaLytica Expo, the premier global pharma trade show and conference. Slated from 1st -3rd June 2022, the three-day expo will be held at the Bombay Exhibition Centre, Mumbai. The focus of PharmaLytica Expo 2022 […]
Mumbai, 28 May 2022: Informa Markets in India, the leading B2B exhibitions organiser, is back with the 8th edition of the PharmaLytica Expo, the premier global pharma trade show and conference. Slated from 1st -3rd June 2022, the three-day expo will be held at the Bombay Exhibition Centre, Mumbai. The focus of PharmaLytica Expo 2022 would be to keep companies abreast with innovations in the growing businesses of India’s pharma industry and achieve the vision of becoming a $130 bn industry by 2030.
The expo, with over 300 topline brands, will present the entire value-added chain in niche segments within the Pharma industry and enable the community to pick up on the latest industry trends and innovations and conduct business with Analytical, Laboratory, Machinery, Packaging and other allied Industries. The show will be marked by over 300 brands and anticipates over 7000 trade visitors and 30 Conference speakers. The key players include Shimadzu, Thermolab, Agilent, Thermo Fisher, Saksham Scientific, SRICO, Newtronics, Mack Pharmatech, Saksham Scientific, Komal Scientific, Sanosil Biotech, Toshvin Analytical, PCI Analytics, Sanitt Equipment, Elmach among many others.
According to Mr. Yogesh Mudras, Managing Director, Informa Markets, India, “We are delighted to bring back the 8th edition of the PharmaLytica Expo in its full offline format, bringing the entire ecosystem of the industry and stakeholders under one roof, to be involved in an integrated endeavour to push the industry to new heights. This aligns with the PM’s vision to Ideate in India, Innovate in India, Make in India and Make for the World. The Government of India allocated Rs. 86,200 Crores (US$ 11.3 Bn) for the Pharma sector in the annual budget for the year 2022-23. This, along with the PLI scheme to reduce the import of bulk drugs and the PM Gati Shakti initiative to improve connectivity, will provide a much-required boost for the Pharmaceutical and Healthcare sector.”
“PharmaLytica, which has over the years catered to the entire pharma supply chain with a keen intent to focus on niche and upcoming sections within it, will further bring to the fore many enterprising ventures providing a unique opportunity for global corporations looking for innovative solutions.” he added.
The two-day conference also marks the event to discuss and deliberate on industry topics, challenges and opportunities towards digitalization, strategies for maintaining a global supply chain in a constrained manner and transforming labs into smart technological labs. The conference will cover topics like API, machinery and manufacturing, lab & analytical, QR Code, supply chain, packaging and labelling, and sterilization. B2B matchmaking and B2B networking will enable industry stalwarts, pharma leaders, technical heads & plant heads, medical heads & scientists, marketing & strategy leaders, R&D heads and technocrats, engineering & production professionals, purchase & packaging professionals, Regulatory Affairs professionals and others to interact and network with exhibitors from across the industry to discuss strategies to charter next phase of growth in the industry.
